Lexeo Therapeutics Growth Metrics (2022-2026) | LXEO

Growth Metrics Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Enterprise Value Growth (1y) (Quarter) 62.35%-57.06%-342.89%-0.04%48.82%24.05%21.81%-49.58%-93.37%-59.30%
Enterprise Value Growth (3y) (Quarter) -9.25%-32.96%
Enterprise Value (QoQ) (Quarter) 17.86%-242.65%-60.59%10.29%10.28%22.60%17.85%-33.12%7.62%-48.06%-6.20%-9.67%
Interest Coverage Ratio Growth (1y) (Quarter) 96.52%-480.34%96.37%95.12%-153.40%106.35%-4,867.23%-146.86%56.44%-158.57%87.24%90.89%
Interest Coverage Ratio Growth (3y) (Quarter) 66.26%-28.89%38.74%47.60%
Interest Coverage Ratio (QoQ) (Quarter) 221.61%-144.70%21.69%91.82%-13,187.74%99.57%-5.32%-324.69%432.72%-433.77%94.77%25.06%-347.38%27.30%-35.16%
Return on Assets Growth (1y) (Quarter) 0.000.000.000.000.000.000.00
Return on Assets (QoQ) (Quarter) 0.000.000.000.000.000.000.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) 872.00-6341.00-5879.00-1976.001,922.007,037.006,332.00
Return on Capital Employed (QoQ) (Quarter) 3,879.00214.00-1512.00-1709.00-3334.00676.002,390.002,189.001,781.00-29.00